Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02). (Q54329995)

From Wikidata

Jump to navigation Jump to search

scientific article published on 10 January 2012

edit

Language	Label	Description	Also known as
English	Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02).	scientific article published on 10 January 2012

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22234739

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22234739

title

Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02). (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22234739

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22234739

main subject

patient

0 references

head and neck squamous cell carcinoma

1 reference

based on heuristic

inferred from title

metastatic squamous cell carcinoma

1 reference

based on heuristic

inferred from title

author

Marc Hamoir

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22234739

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22234739

author name string

S Schmitz

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22234739

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22234739

M-C Kaminsky-Forrett

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22234739

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22234739

S Henry

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22234739

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22234739

S Zanetta

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22234739

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22234739

L Geoffrois

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22234739

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22234739

E Bompas

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22234739

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22234739

A Moxhon

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22234739

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22234739

L Mignion

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22234739

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22234739

J Guigay

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22234739

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22234739

L Knoops

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22234739

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22234739

J-P Machiels

series ordinal

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22234739

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22234739

publication date

10 January 2012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22234739

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22234739

published in

Annals of Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22234739

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22234739

volume

23

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22234739

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22234739

issue

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22234739

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22234739

page(s)

2153-2161

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22234739

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22234739

Identifiers

DOI

10.1093/ANNONC/MDR574

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22234739

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22234739

Fatcat ID

release_sit6nygczjfgngrmdfg7jtvkke

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/sit6nygczjfgngrmdfg7jtvkke

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

22234739

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22234739

retrieved

27 May 2018

reference URL

http://europepmc.org/abstract/MED/22234739

ResearchGate publication ID

221738084

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54329995&oldid=1842860941"